DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 54,100 shares, an increase of 14.6% from the December 31st total of 47,200 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 541.0 days.
DiaSorin Price Performance
DiaSorin stock opened at $102.64 on Monday. DiaSorin has a fifty-two week low of $102.64 and a fifty-two week high of $108.79. The firm has a fifty day moving average price of $106.46 and a two-hundred day moving average price of $103.03.
Wall Street Analyst Weigh In
Separately, UBS Group cut shares of DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- What is the Shanghai Stock Exchange Composite Index?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- Using the MarketBeat Dividend Tax Calculator
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.